跳至主要内容
临床试验/NCT02066727
NCT02066727已完成不适用

Effects of Dexmedetomidine as an Adjuvant on the Median Effective Concentration of Lidocaine for Obturator Nerve Block - A Perspective, Randomized,Blind Study

Guolin Wang1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Median Effective Concentration(EC50)

研究概览

简要总结

Hypothesis: Dexmedetomidine as an adjuvant of lidocaine can decrease the median effective concentration(EC50) of lidocaine for obturator nerve block during transurethral resection of bladder tumor

详细描述

A selective obturator nerve block(ONB) is an effective alternative to suppress the obturator nerve reflex which is defined as a sudden, violent adductor muscle spasm when the obturator nerve is stimulated directly by the electronic resector during transurethral resection of the tumor on the lateral bladder wall. Studies showed Dexmedetomidine as an adjuvant to local anesthetic prolongs peripheral nerve block duration without any nerve toxicity. In the following randomized, non-crossover study, the investigators test if Dexmedetomidine as an adjuvant can decrease the median effective concentration(EC50) of lidocaine for obturator nerve block during transurethral resection of bladder tumor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects scheduled to undergo elective operation of TURBT on lateral wall for whom ONB was needed diagnosed through cystoscopy or CT examination preoperatively.
  • Subject's American Society of Anesthesiologists physical status is I-II.
  • The subject's parent/legally authorized guardian has given written informed consent to participate.

排除标准

  • Subject has a diagnosis of abnormal coagulation function.
  • Subject has a diagnosis of Diabetes mellitus.
  • Subject has a preexisting neurologic deficits of the lower extremities.
  • Subject has a history of alcohol or drug abuse.
  • Subject is pregnant or breast-feeding.
  • Subject is obese (body mass index >30kg/m2).

研究组 & 干预措施

Dexmedetomidine

Active Comparator

Dexmedetomidine is administrated as an adjuvant of lidocaine at a dose of 1.0 μg/ kg.

干预措施: Dexmedetomidine (Drug)

Normal Saline

Placebo Comparator

Normal Saline is administrated as an adjuvant of lidocaine.

干预措施: Normal Saline (Drug)

结局指标

主要结局

Median Effective Concentration(EC50)

时间窗: 10min

Median effective concentration(EC50) was not calculated per-participants, the "up-and-down" sequential allocation method was used to determine the median effective concentration(EC50) of lidocaine, running the two groups in parallel. The concentration of lidocaine for the second and subsequent patients in each group were dictated by the response of the previous patient in the group, such that an effective block led to a decreased concentration of the next patient, an ineffective block led to an increased concentration. For each group, we collected: the logarithm of lidocaine concentration, the number of effective block, ineffective block, total number of the patient, and successful rate. Then lgEC50 and slgEC50 was calculated as formulas. The logarithm of confidence intervals(95% CI) was calculated as lgEC50±1.96slgEC50. All of the calculation can be performed by SPSS19.0 for windows.

次要结局

  • Complication Related With Nerve Block(during operation, 0.5,24hour postoperatively)

研究者

发起方
Guolin Wang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Guolin Wang

Tianjin Medical University General Hospital

Tianjin Medical University General Hospital

研究点 (1)

Loading locations...

相似试验